In contrast to the regulation of HIF-1α on PDGF, it has also been demonstrated that PDGF-BB treatment can rapidly increase the nucleus level of HIF-1 to activate transcription of myeloid cell leukemia-1 (Mcl-1) in human prostate cancer cells [36]. This evidence concerns the gene MCL1 and prostate carcinoma.